Related references
Note: Only part of the references are listed.Adenovirus vector-based vaccine for infectious diseases
Fuminori Sakurai et al.
DRUG METABOLISM AND PHARMACOKINETICS (2022)
HydrAd: A Helper-Dependent Adenovirus Targeting Multiple Immune Pathways for Cancer Immunotherapy
Amanda Rosewell Shaw et al.
CANCERS (2022)
A Human In Vitro Model to Study Adenoviral Receptors and Virus Cell Interactions
Raphael L. Tsoukas et al.
CELLS (2022)
A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity
Kenta Matsuda et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Adenovirus vector-attributed hepatotoxicity blocks clinical application in gene therapy
Zeng Wang et al.
CYTOTHERAPY (2021)
Did Dendritic Cell Activation, Induced by Adenovirus-Antibody Complexes, Play a Role in the Death of Jesse Gelsinger?
Andrew H. Baker et al.
MOLECULAR THERAPY (2020)
Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors
Caroline E. Porter et al.
MOLECULAR THERAPY (2020)
Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccine
Kenta Matsuda et al.
SCIENCE IMMUNOLOGY (2019)
MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization
Kazutaka Katoh et al.
BRIEFINGS IN BIOINFORMATICS (2019)
The Repertoire of Adenovirus in Human Disease: The Innocuous to the Deadly
Subrat Khanal et al.
BIOMEDICINES (2018)
An Engineered Virus Library as a Resource for the Spectrum-wide Exploration of Virus and Vector Diversity
Wenli Zhang et al.
CELL REPORTS (2017)
Adenovirus-mediated gene delivery: Potential applications for gene and cell-based therapies in the new era of personalized medicine
Cody S. Lee et al.
GENES & DISEASES (2017)
Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based Constructs
Julio Alonso-Padilla et al.
MOLECULAR THERAPY (2016)
Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01
Beatriz Vera et al.
PLOS ONE (2016)
Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications
Hanni Uusi-Kerttula et al.
VIRUSES-BASEL (2015)
Dramatic Decline of Respiratory Illness Among US Military Recruits After the Renewed Use of Adenovirus Vaccines
Jennifer M. Radin et al.
CLINICAL INFECTIOUS DISEASES (2014)
Activity of a group B oncolytic adenovirus (ColoAd1) in whole human blood
Y. Di et al.
GENE THERAPY (2014)
Establishment and validation of new complementing cells for production of E1-deleted adenovirus vectors in serum-free suspension culture
Renald Gilbert et al.
JOURNAL OF VIROLOGICAL METHODS (2014)
Molecular typing of adenoviruses in pediatric respiratory infections in Buenos Aires, Argentina (1999-2010)
P. R. Barrero et al.
JOURNAL OF CLINICAL VIROLOGY (2012)
Seroprevalence of neutralizing antibodies to human adenovirus type 5 in healthy adults in China
Bin Yu et al.
JOURNAL OF MEDICAL VIROLOGY (2012)
A Molecular Epidemiology Survey of Respiratory Adenoviruses Circulating in Children Residing in Southern Palestine
Lina Qurei et al.
PLOS ONE (2012)
Adenovirus Respiratory Infections in Hospitalized Children Clinical Findings in Relation to Species and Serotypes
Irena Tabain et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials
T. Christopher Mast et al.
VACCINE (2010)
A rapid protocol for construction and production of high-capacity adenoviral vectors
Lorenz Jager et al.
NATURE PROTOCOLS (2009)
Isolation and Characterization of Adenoviruses Persistently Shed from the Gastrointestinal Tract of Non-Human Primates
Soumitra Roy et al.
PLOS PATHOGENS (2009)
Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer
Irene Kuhn et al.
PLOS ONE (2008)
Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa
Zhiquan Xiang et al.
EMERGING INFECTIOUS DISEASES (2006)
Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors
B Sangro et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Functions and mechanisms of action of the adenovirus E3 proteins
DL Lichtenstein et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2004)
Share Paper
